Cerbo's Parent Gets a Name. DPC Is One of Eight Markets on Its List

The EHR company behind Cerbo and OptiMantra has a single name now, and the way it describes its own market says a lot about where a DPC practice sits on its list of priorities.

Providi launched on Oct. 27 as the corporate brand over both products. The release says the two companies combined in 2025 “backed by a growth investment from Mainsail Partners,” and that Cerbo and OptiMantra will keep their names as product brands. Together, the company says, they support “nearly 7,000 clinics.”

Then comes the list. Those clinics include “functional, integrative, longevity, wellness, direct primary care, concierge, med spa and behavioral health practices.” DPC is one entry of eight.

What the release counts, and what it doesn’t

The 7,000 figure is the whole company. It covers med spas and longevity clinics as much as membership primary care. The release doesn’t say how many of those clinics are DPC practices, and the Providi website doesn’t either. It describes “thousands of clinics in the cash-pay personalized care market.”

That phrase is the company’s chosen frame, and it’s a reasonable one. A DPC practice and a med spa share a lot of plumbing. Both bill patients directly. Both sell memberships or packages. Neither wants a claims engine at the center of the chart.

But a DPC practice also needs things a wellness clinic might not: chronic disease management, tracking across a whole patient panel, referrals and lab ordering at primary care volume. When one company serves eight markets, those needs compete for the same engineering hours.

The release names no DPC-specific feature. Its one concrete product item is an AI scribe.

The merger came first

None of the corporate change is new this week. Pulse 2.0 reported in December 2025 that Cerbo and OptiMantra had formally merged and named technology executive Jeff Hindman as chief executive. In that report, former Cerbo CEO Jonathan Dunn said the deal would position the company “for its next stage of growth.”

Providi’s own site says Mainsail Partners has been its “strategic investor and partner” since 2025. Neither the release nor the site discloses the terms.

What is new is the name, and with it a single story to tell investors and buyers. Hindman put it this way in the Oct. 27 release: “Coming together as one company accelerates the innovation we can bring to market and enables us to invest more in both products.”

What stays the same, by the company’s account

For a practice already on Cerbo, the release is specific. Providers “can expect to log in to the same Cerbo and OptiMantra products, reach out to the same reps and receive support, onboarding and product updates the same way they do today.” The Providi name will show up “at combined events and in company communications.”

The visible product change so far is the scribe. Cerbo launched AI Scribe on Aug. 17, describing it as a tool that listens to the visit and drafts a structured note in the chart for the provider to review and sign. The company priced it starting at $29 per provider per month, with a limited-time unlimited tier at $59. Prices are the company’s own and can change.

The Providi release says an OptiMantra version, “built on lessons from the Cerbo launch,” is “coming to OptiMantra providers soon.” That is the first test of the merger’s pitch: two teams, shared work, faster releases.

You might read that as a plus. A small DPC practice can’t fund its own software development, and a larger vendor with a growth investor behind it can ship features a two-person company couldn’t. You might also read it as a shift in who the customer is. A vendor with a growth investor behind it might build first for whichever segment grows fastest, and the release doesn’t say which segment that is.

What To Watch

Three signals will say more than the release did.

The first is the OptiMantra scribe date. The company called it “soon.” When it ships, and whether it matches Cerbo’s pricing, will show how fast the shared-team promise actually moves.

The second is the first combined event. The release says the Providi name will appear at combined events. Watch which practice types get the stage and the session slots. If DPC shows up as one track among eight, that’s the company telling you its weighting.

The third is pricing at renewal. The release promises the same products and the same support. It doesn’t mention price. A practice on Cerbo should check its next renewal notice against what it pays now, and ask its rep in writing whether plan terms are changing under the new parent.

If you run a DPC practice on Cerbo, none of this calls for a move today. It does call for keeping a current export of your patient data, which is good practice with any EHR, and for reading the next few product announcements with one question in mind: is this built for a membership primary care panel, or for the other seven markets on the list?